Introduction to Nuclear Medicine
History of Nuclear Medicine
Industry Growth
A History of Nuclear Medicine
The potential of nuclear medicine was first demonstrated in the 1940s, when radioactive iodine was used to diagnose and treat thyroid cancer.

1970s: Nuclear medicine recognized as a medical specialty by the AMA and widely adopted to scan the liver and spleen, pinpoint brain tumors, and study the gastrointestinal tract

1980s: Radiopharmaceuticals, developed to aid in the diagnosis of cardiovascular disease and many forms of cancer, were able to detect disease at early stages, when it was still invisible to other imaging methods, such as CT and MRI

1990s: Radiopharmaceuticals capable of acting as imaging agents—compounds that showed how they were distributed in the body and metabolized by specific organs—made Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) diagnostic tools of unprecedented value for the detection of a number of diseases

2000s: PET/CT fusion, which combines the CT’s structural information with the metabolic data from PET, adds crucial precision about the site of disease that often makes safer, targeted treatment regimens possible

Tour our up and coming state-of-the-art manufacturing facility

The radionuclides employed for imaging purposes are isotopes of radioactive elements such as uranium or iodine that produce gamma rays with high penetrating power that can be recorded by a gamma camera or scintillation detector that captures the images..>

View a quick presentation of the science behind radio-pharmaceuticals.
461 Park Avenue South
New York, NY 10016

Office:  212-719-2322
Fax: (212) 997-4119


© NCM USA LLC 2011 All Rights Reserved Home Contact us Investor Relations